Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.

Udina M, Moreno-España J, Navinés R, Giménez D, Langohr K, Gratacòs M, Capuron L, de la Torre R, Solà R, Martín-Santos R.

Psychoneuroendocrinology. 2013 Sep;38(9):1803-13. doi: 10.1016/j.psyneuen.2013.03.007. Epub 2013 Apr 6.

PMID:
23571152
[PubMed - indexed for MEDLINE]
2.

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.

Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, Miyazaki C, Alexander N, Hotopf M, Cleare AJ, Norris S, Cassidy E, Aitchison KJ, Miller AH, Pariante CM.

Mol Psychiatry. 2009 Dec;14(12):1095-104. doi: 10.1038/mp.2008.48. Epub 2008 May 6.

PMID:
18458677
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms.

Loftis JM.

Psychoneuroendocrinology. 2013 Sep;38(9):1829-30. doi: 10.1016/j.psyneuen.2013.05.020. Epub 2013 Jun 27. No abstract available.

PMID:
23810316
[PubMed - indexed for MEDLINE]
5.

Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.

Schäfer A, Scheurlen M, Seufert J, Keicher C, Weissbrich B, Rieger P, Kraus MR.

J Hepatol. 2010 Jan;52(1):10-5. doi: 10.1016/j.jhep.2009.10.007. Epub 2009 Oct 21.

PMID:
19897271
[PubMed - indexed for MEDLINE]
6.

Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.

Felger JC, Alagbe O, Pace TW, Woolwine BJ, Hu F, Raison CL, Miller AH.

Brain Behav Immun. 2011 Aug;25(6):1094-8. doi: 10.1016/j.bbi.2011.02.015. Epub 2011 Feb 26.

PMID:
21356304
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C.

Smith AK, Simon JS, Gustafson EL, Noviello S, Cubells JF, Epstein MP, Devlin DJ, Qiu P, Albrecht JK, Brass CA, Sulkowski MS, McHutchinson JG, Miller AH.

Mol Psychiatry. 2012 Jul;17(8):781-9. doi: 10.1038/mp.2011.67. Epub 2011 Jun 21.

PMID:
21691274
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.

Maddock C, Baita A, Orrù MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM.

J Psychopharmacol. 2004 Mar;18(1):41-6.

PMID:
15107183
[PubMed - indexed for MEDLINE]
9.

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.

Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study [KULDS] Group.

J Gastroenterol Hepatol. 2012 Jul;27(7):1233-40. doi: 10.1111/j.1440-1746.2011.06965.x.

PMID:
22098185
[PubMed - indexed for MEDLINE]
10.

Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

Loftis JM, Patterson AL, Wilhelm CJ, McNett H, Morasco BJ, Huckans M, Morgan T, Saperstein S, Asghar A, Hauser P.

J Psychosom Res. 2013 Jan;74(1):57-63. doi: 10.1016/j.jpsychores.2012.10.012. Epub 2012 Nov 21.

PMID:
23272989
[PubMed - indexed for MEDLINE]
11.

[Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].

Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.

Encephale. 2009 Oct;35(5):477-83. doi: 10.1016/j.encep.2007.09.007. Epub 2008 Jun 12. French.

PMID:
19853722
[PubMed - indexed for MEDLINE]
12.

Efficacy of peginterferon alpha-2A and ribavirin combination therapy in treatment-naive Estonian patients with chronic hepatitis C.

Brjalin V, Salupere R, Tallo T, Kuznetsova T, Priimägi L, Tefanova V.

Cent Eur J Public Health. 2012 Jun;20(2):150-5.

PMID:
22966742
[PubMed - indexed for MEDLINE]
13.

[Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].

García-Toro M, Vilella Martorell A, Carral Martínez M, Jimeno Beltrán T, Román Ruiz del Moral Y, Pradas Guerrero C, Gili Planas M, Roca Bennasar M.

Gastroenterol Hepatol. 2011 Apr;34(4):307-8. doi: 10.1016/j.gastrohep.2010.11.004. Epub 2011 Mar 3. Spanish. No abstract available.

PMID:
21376422
[PubMed - indexed for MEDLINE]
14.

Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.

Felger JC, Cole SW, Pace TW, Hu F, Woolwine BJ, Doho GH, Raison CL, Miller AH.

Psychol Med. 2012 Aug;42(8):1591-603. doi: 10.1017/S0033291711002868. Epub 2011 Dec 9.

PMID:
22152193
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.

Schaefer M, Mauss S.

Curr Drug Abuse Rev. 2008 Jun;1(2):177-87. Review.

PMID:
19630716
[PubMed - indexed for MEDLINE]
16.

Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.

Kraus MR, Al-Taie O, Schäfer A, Pfersdorff M, Lesch KP, Scheurlen M.

Gastroenterology. 2007 Apr;132(4):1279-86. Epub 2007 Feb 25.

PMID:
17408646
[PubMed - indexed for MEDLINE]
17.

Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.

Di Marco V, Calvaruso V, Grimaudo S, Ferraro D, Pipitone RM, Di Stefano R, Craxì A.

J Viral Hepat. 2013 Feb;20(2):113-21. doi: 10.1111/j.1365-2893.2012.01637.x. Epub 2012 Jul 25.

PMID:
23301546
[PubMed - indexed for MEDLINE]
18.

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Schaefer M, Hinzpeter A, Mohmand A, Janssen G, Pich M, Schwaiger M, Sarkar R, Friebe A, Heinz A, Kluschke M, Ziemer M, Gutsche J, Weich V, Halangk J, Berg T.

Hepatology. 2007 Oct;46(4):991-8.

PMID:
17668880
[PubMed - indexed for MEDLINE]
19.

Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.

Galán RJ, Cidoncha EC, Martin MF, Rodriguez CC, Almeida CV, Verdugo RM.

J Manag Care Pharm. 2013 Jul-Aug;19(6):448-53.

PMID:
23806058
[PubMed - indexed for MEDLINE]
Free Article
20.

Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus.

Wackernah RC, Lou M, Park SH.

Clin Ther. 2011 Oct;33(10):1400-5. doi: 10.1016/j.clinthera.2011.09.002. Epub 2011 Oct 7.

PMID:
21982383
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk